Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 13, 2024
The HALP score as a prognostic factor in metastatic biliary cancerİsmet Seven, İrfan Karahan, Fahriye Tuğba Köş, et al.
International Urology and Nephrology|December 27, 2024
Clinicopathological features and treatment outcomes of urothelial carcinoma variant histologies and non-urothelial bladder cancersİsmet Seven, Selin Aktürk Esen, Serhat Sekmek, et al.
Diagnostics (Basel, Switzerland)|August 28, 2025
Anorectal Malignant Melanoma: Diagnostic Pitfalls and Prognostic Insights from a Single-Center Retrospective AnalysisEmre Hafızoğlu, Murat Bardakçı, Yakup Ergun, et al.
Biomarkers in Medicine|August 3, 2025
The predictive value of sarcopenia and PET imaging metrics in metastatic non-squamous NSCLCİsmet Seven, Mehmet Akif Karacan, Semanur Özsan Çelebi, et al.
Journal of Ovarian Research|June 16, 2026
Low muscle mass predicts poor response to neoadjuvant chemotherapy in advanced ovarian cancerDerya Demirtaş Esmer, Emre Hafızoğlu, Murat Bardakçı, et al.
Anti-Cancer Drugs|January 3, 2025
A rare EGFR exon 19 insertion mutation in metastatic lung adenocarcinoma: a favorable response to afatinibİsmet Seven, Fahriye Tuğba Köş, Hayriye Tatli Doğan, et al.
Oncology Research and Treatment|December 1, 2024
Prognostic Significance of HER2 Positivity in Endometrium CancerSerhat Sekmek, Dogan Bayram, Irfan Karahan, et al.
Oncology Research and Treatment|April 10, 2025
The Effect of Positron Emission Tomography-Computed Tomography Parameters on Pathological Response in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant TreatmentSerhat Sekmek, Ozkan Bayrakcı, Mehmet Akif Karacan, et al.
Medicina (Kaunas, Lithuania)|April 26, 2025
Prognostic Factors and Long-Term Survival in Kaposi's Sarcoma Patients: Results from a 28-Year Retrospective CohortEmre Hafızoğlu, Murat Bardakçı, Yakup Ergun, et al.
Journal of Clinical Medicine|May 27, 2026
The Royal Marsden Hospital Score Independently Predicts Overall Survival in Patients with De Novo Metastatic Renal Cell Carcinoma Treated with First-Line Tyrosine Kinase Inhibitors: A Multicenter Retrospective AnalysisTolga Doğan, Semra Taş, Taliha Güçlü Kantar, et al.
Pageof 3